Operation of the Acquired Corporations’ Business. During the Pre-Closing Period, except (x) as required or expressly provided by this Agreement or as required by applicable Legal Requirements, (y) with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), or (z) with respect to Section 4.2(a), as set forth in Section 4.2(a) of the Company Disclosure Schedule and with respect to Section 4.2(b), as set forth in Section 4.2(b) of the Company Disclosure Schedule:
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Mirati Therapeutics, Inc.), Agreement and Plan of Merger (Mirati Therapeutics, Inc.)
Operation of the Acquired Corporations’ Business. During the Pre-Closing Period, except (x) as expressly required or expressly provided by this Agreement or as required by any applicable Legal Requirements, Requirement; (y) with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), ; or (z) with respect to Section 4.2(a), as set forth in Section 4.2(a) of the Company Disclosure Schedule and with respect to Section 4.2(b), as set forth in Section 4.2(b) 5.2 of the Company Disclosure Schedule:
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Celgene Corp /De/), Agreement and Plan of Merger (Juno Therapeutics, Inc.)
Operation of the Acquired Corporations’ Business. During the Pre-Closing Period, except (xw) as required or expressly provided by permitted under this Agreement or as required by applicable Legal Requirements, (yx) with the prior written consent of Parent (which such consent shall not to be unreasonably withheld, conditioned delayed or delayed)conditioned) or as caused by Parent or its Affiliates, or (zy) with respect to Section 4.2(a), as set forth in Section 4.2(a) of the Company Disclosure Schedule and with respect to Section 4.2(b), as set forth in Section 4.2(b) 5.2 of the Company Disclosure Schedule:
Appears in 1 contract
Samples: Agreement and Plan of Merger (Akcea Therapeutics, Inc.)
Operation of the Acquired Corporations’ Business. During the Pre-Closing Period, except (x) as required or expressly provided by otherwise contemplated under this Agreement or as required by applicable Legal Requirements, (y) with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), or (z) with respect to Section 4.2(a), as set forth in Section 4.2(a) of the Company Disclosure Schedule and with respect to Section 4.2(b), as set forth in Section 4.2(b) 5.2 of the Company Disclosure Schedule:
Appears in 1 contract
Samples: Agreement and Plan of Merger (Intercept Pharmaceuticals, Inc.)
Operation of the Acquired Corporations’ Business. During the Pre-Closing Period, except (x) as expressly required or expressly provided by under this Agreement or as required by applicable Legal Requirements, (y) with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), or (z) with respect to Section 4.2(a), as set forth in Section 4.2(a) of the Company Disclosure Schedule and with respect to Section 4.2(b), as set forth in Section 4.2(b) 4.2 of the Company Disclosure Schedule:
Appears in 1 contract
Operation of the Acquired Corporations’ Business. During the Pre-Closing Period, except (x) as expressly required or expressly provided by under this Agreement or as required by applicable Legal Requirements, (y) with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), or (z) with respect to Section 4.2(a), as set forth in Section 4.2(a) of the Company Disclosure Schedule and with respect to Section 4.2(b), as set forth in Section 4.2(b) 5.2 of the Company Disclosure Schedule:
Appears in 1 contract
Operation of the Acquired Corporations’ Business. During the Pre-Closing Period, except (xi) as expressly required or expressly provided by this Agreement or as required by applicable Legal Requirements, (yii) with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), ) or (ziii) with respect to Section 4.2(a), as set forth in Section 4.2(a) of the Company Disclosure Schedule and with respect to Section 4.2(b), as set forth in Section 4.2(b5.2(A) of the Company Disclosure Schedule:
Appears in 1 contract